Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiography, Dual-Energy Scanned Projection | 1 | 2018 | 5 | 0.650 |
Why?
|
| Practice Management, Medical | 1 | 2018 | 8 | 0.650 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2018 | 912 | 0.630 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2017 | 22 | 0.370 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2019 | 1323 | 0.320 |
Why?
|
| Intracranial Hypertension | 2 | 2018 | 21 | 0.270 |
Why?
|
| Ear, Inner | 2 | 2017 | 9 | 0.260 |
Why?
|
| Temporal Bone | 2 | 2013 | 21 | 0.220 |
Why?
|
| DiGeorge Syndrome | 2 | 2012 | 11 | 0.210 |
Why?
|
| Ear Diseases | 1 | 2021 | 7 | 0.190 |
Why?
|
| Cervical Vertebrae | 1 | 2021 | 44 | 0.180 |
Why?
|
| Restraint, Physical | 1 | 2019 | 10 | 0.170 |
Why?
|
| Workflow | 1 | 2018 | 21 | 0.160 |
Why?
|
| Sleep | 1 | 2019 | 92 | 0.160 |
Why?
|
| Subdural Effusion | 1 | 2018 | 5 | 0.160 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 38 | 0.160 |
Why?
|
| Papilledema | 1 | 2018 | 13 | 0.160 |
Why?
|
| Child | 8 | 2021 | 2425 | 0.160 |
Why?
|
| Cerebrospinal Fluid | 1 | 2018 | 13 | 0.160 |
Why?
|
| Orbit | 1 | 2018 | 19 | 0.160 |
Why?
|
| Feeding Behavior | 1 | 2019 | 161 | 0.160 |
Why?
|
| Software | 1 | 2018 | 127 | 0.150 |
Why?
|
| Cerebellopontine Angle | 1 | 2017 | 3 | 0.150 |
Why?
|
| Cerebellar Diseases | 1 | 2017 | 4 | 0.150 |
Why?
|
| Labyrinth Diseases | 1 | 2017 | 7 | 0.150 |
Why?
|
| Infant | 5 | 2021 | 1055 | 0.140 |
Why?
|
| Decision Making | 1 | 2018 | 194 | 0.140 |
Why?
|
| Child, Preschool | 5 | 2021 | 1259 | 0.140 |
Why?
|
| Accidental Falls | 1 | 2018 | 221 | 0.140 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2016 | 11 | 0.140 |
Why?
|
| Huntington Disease | 1 | 2016 | 15 | 0.140 |
Why?
|
| Humans | 15 | 2021 | 31836 | 0.130 |
Why?
|
| Clinical Competence | 1 | 2018 | 325 | 0.130 |
Why?
|
| Retrospective Studies | 6 | 2021 | 3488 | 0.120 |
Why?
|
| Ear | 1 | 2013 | 18 | 0.110 |
Why?
|
| Rocky Mountain Spotted Fever | 1 | 2013 | 8 | 0.110 |
Why?
|
| Infant, Newborn | 3 | 2021 | 665 | 0.110 |
Why?
|
| Exanthema | 1 | 2013 | 21 | 0.110 |
Why?
|
| Male | 11 | 2021 | 19091 | 0.110 |
Why?
|
| Aspartic Acid | 1 | 2012 | 12 | 0.100 |
Why?
|
| Corpus Callosum | 1 | 2012 | 18 | 0.100 |
Why?
|
| Dipeptides | 1 | 2012 | 9 | 0.100 |
Why?
|
| Osteoclasts | 1 | 2012 | 22 | 0.100 |
Why?
|
| Brain | 1 | 2019 | 949 | 0.100 |
Why?
|
| Brain Neoplasms | 2 | 2016 | 638 | 0.100 |
Why?
|
| Sex Characteristics | 1 | 2013 | 169 | 0.100 |
Why?
|
| Prefrontal Cortex | 1 | 2012 | 70 | 0.100 |
Why?
|
| Medulloblastoma | 1 | 2010 | 7 | 0.090 |
Why?
|
| Cerebellar Neoplasms | 1 | 2010 | 11 | 0.090 |
Why?
|
| Female | 10 | 2021 | 19859 | 0.090 |
Why?
|
| Angiotensin I | 1 | 2012 | 240 | 0.090 |
Why?
|
| Radiotherapy | 1 | 2010 | 82 | 0.090 |
Why?
|
| Medical Records | 1 | 2010 | 76 | 0.090 |
Why?
|
| Radiology | 1 | 2010 | 41 | 0.090 |
Why?
|
| Age Factors | 3 | 2019 | 1187 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 311 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2012 | 398 | 0.080 |
Why?
|
| Cognition Disorders | 1 | 2012 | 384 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 1067 | 0.080 |
Why?
|
| Adolescent | 4 | 2021 | 3511 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 470 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 607 | 0.070 |
Why?
|
| Bedding and Linens | 1 | 2019 | 6 | 0.040 |
Why?
|
| Infant Formula | 1 | 2019 | 11 | 0.040 |
Why?
|
| Milk, Human | 1 | 2019 | 16 | 0.040 |
Why?
|
| Prevalence | 1 | 2021 | 979 | 0.040 |
Why?
|
| Middle Aged | 3 | 2021 | 11824 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 53 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2016 | 67 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 2016 | 60 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 192 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 10288 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 2603 | 0.030 |
Why?
|
| Adult | 2 | 2021 | 9327 | 0.030 |
Why?
|
| Rickettsia rickettsii | 1 | 2013 | 3 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2013 | 81 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 3988 | 0.030 |
Why?
|
| Acyltransferases | 1 | 2012 | 16 | 0.030 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2012 | 14 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2013 | 461 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2012 | 11 | 0.030 |
Why?
|
| Protons | 1 | 2012 | 23 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 121 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2012 | 71 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 82 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2012 | 114 | 0.030 |
Why?
|
| Organ Size | 1 | 2012 | 208 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 110 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 121 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 298 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2012 | 290 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 221 | 0.020 |
Why?
|
| Proteins | 1 | 2012 | 144 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 662 | 0.020 |
Why?
|
| Craniopharyngioma | 1 | 2010 | 8 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 370 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2012 | 111 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2010 | 41 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 35 | 0.020 |
Why?
|
| Pituitary Neoplasms | 1 | 2010 | 17 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2012 | 257 | 0.020 |
Why?
|
| Peer Review, Health Care | 1 | 2010 | 4 | 0.020 |
Why?
|
| Astrocytoma | 1 | 2010 | 29 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 725 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 895 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 598 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 1527 | 0.020 |
Why?
|
| Mice | 1 | 2012 | 2476 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2010 | 1824 | 0.020 |
Why?
|
| Animals | 1 | 2012 | 7450 | 0.010 |
Why?
|